Skip to main content

Sonoma Pharmaceuticals, Inc.

corporate_fare Company Profile

Sonoma Pharmaceuticals, Inc.

SNOA·NASDAQ·Industrial Applications And Services·CIK 0001367083

Sonoma Pharmaceuticals, Inc. is a global healthcare company that develops and produces stabilized hypochlorous acid (HOCl) products. These products are used in various applications such as wound care, eye care, dermatological conditions, podiatry, animal health care, and as non-toxic disinfectants. The company's products are clinically proven to safely reduce itch, pain, scarring, and irritation without damaging healthy tissue. In-vitro and clinical studies demonstrate that HOCl can safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma Pharmaceuticals sells its products directly or through partners in over 55 countries worldwide. The company has two active wholly-owned subsidiaries: Oculus Technologies of Mexico, S.A. de C.V., and Sonoma Pharmaceuticals Netherlands, B.V. Its principal executive offices are located in Boulder, Colorado. The company's fiscal year ends on March 31. In March 2026, Sonoma Pharmaceuticals launched its advanced HOCl-based burn relief hydrogel in CVS and Walmart stores across the United States.

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for SNOA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for SNOA spans S-3, 10-Q, DEFA14A, 424B5.

Recent high-impact activity:

  • Sonoma Files New $46.65M Shelf to Replace Expiring S-3
  • Sonoma Posts $2.8M Q2 Gross Profit as Revenue Jumps 28% to $7.2M
  • Sonoma Q2 Revenue Up 28% to $7.2M, Near Breakeven; WellSpring Contract Terminated
  • Sonoma Pharma Q1 Revenue Jumps 60% to $6.4M, Nears Breakeven
  • Sonoma Nears Breakeven as Revenue Jumps 60%, But Nasdaq Delisting Risk Looms

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$19.53M
Net Income
-$3.17M
Diluted EPS
-$1.89
Op. Cash Flow
-$3.93M
Free Cash Flow
-$4.13M
Gross Profit
$7.42M
Operating Income
-$2.46M
Cash & Equivalents
$2.4M
Total Debt
$222K
Debt / Equity
0.07×
Net Margin
-16.3%
Shares Outstanding
1.8M sh
Source: 10-K · filed 2026-06-16 · accession 0001683168-26-004871

Short Interest & Short Volume

1.67 days to cover

FINRA reported short interest of 66,674 shares in SNOA as of the October 30, 2026 settlement, a 38.7% decrease from the prior period — about 1.7 days to cover at its recent average daily volume. On November 20, 2026, 21.8% of SNOA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)66,674 shares as of October 30, 2026
Change vs prior period▼ 38.7%
Days to cover1.67 at avg daily volume of 39,962
Daily short volume (FINRA facilities)21.8% of 46,537 shares on November 20, 2026
5-day average short volume14.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for SNOA, detected from its recent SEC filings · based on capital-structure filings through 2026-06-18.

1 recent capital raiseATM program1 shelf registration

ATM Program Expansion · Recent Stock Sales Reported

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with S →
$0.81 -2.17% today
52-week range · as of 2026-11-13 $0.81 – $3.95
Market cap
$3.65M
Volume
103.7K (1.4× avg)
3-mo avg 73.4K
Live data · 2026-11-21 06:22 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SNOA - Latest Insights

SNOA
Nov 13, 2026, 4:31 PM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.09
Real-time Price: $0.810 info
Change: -$0.280 (-26%) info
Market Cap: $3.654M info
SNOA
Nov 10, 2026, 4:13 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $0.810 info
Change: -$0.3376 (-29%) info
Market Cap: $3.654M info
SNOA
Nov 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.810 info
Change: -$0.330 (-29%) info
Market Cap: $3.654M info
SNOA
Aug 06, 2026, 9:07 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $0.810 info
Change: -$0.350 (-30%) info
Market Cap: $3.654M info
SNOA
Aug 06, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $0.810 info
Change: -$0.390 (-32%) info
Market Cap: $3.654M info
SNOA
Jun 24, 2026, 5:17 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $0.810 info
Change: -$0.340 (-30%) info
Market Cap: $3.654M info
SNOA
Jun 18, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.15
Real-time Price: $0.810 info
Change: -$0.340 (-30%) info
Market Cap: $3.654M info
SNOA
Jun 18, 2026, 4:30 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.15
Real-time Price: $0.810 info
Change: -$0.340 (-30%) info
Market Cap: $3.654M info
SNOA
Jun 16, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.10
Real-time Price: $0.810 info
Change: -$0.290 (-26%) info
Market Cap: $3.654M info
SNOA
Jun 16, 2026, 4:02 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.10
Real-time Price: $0.810 info
Change: -$0.290 (-26%) info
Market Cap: $3.654M info
SNOA
May 05, 2026, 4:55 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.23
Real-time Price: $0.810 info
Change: -$0.420 (-34%) info
Market Cap: $3.654M info
SNOA
Apr 30, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.08
Real-time Price: $0.810 info
Change: -$0.270 (-25%) info
Market Cap: $3.654M info
SNOA
Apr 27, 2026, 6:00 AM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $1.13
Real-time Price: $0.810 info
Change: -$0.320 (-28%) info
Market Cap: $3.654M info
SNOA
Apr 24, 2026, 9:21 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $0.810 info
Change: -$0.320 (-28%) info
Market Cap: $3.654M info
SNOA
Apr 24, 2026, 9:22 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $1.30
Real-time Price: $0.810 info
Change: -$0.490 (-38%) info
Market Cap: $3.654M info
SNOA
Apr 22, 2026, 8:07 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $2.14
Real-time Price: $0.810 info
Change: -$1.33 (-62%) info
Market Cap: $3.654M info
SNOA
Apr 17, 2026, 5:33 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $2.30
Real-time Price: $0.810 info
Change: -$1.49 (-65%) info
Market Cap: $3.654M info
SNOA
Apr 17, 2026, 5:23 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $2.30
Real-time Price: $0.810 info
Change: -$1.49 (-65%) info
Market Cap: $3.654M info
SNOA
Apr 09, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.40
Real-time Price: $0.810 info
Change: -$1.59 (-66%) info
Market Cap: $3.654M info
SNOA
Feb 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.76
Real-time Price: $0.810 info
Change: -$1.95 (-71%) info
Market Cap: $3.654M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets